MOMENTA PHARMACEUTICALS INC - COM (MNTA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2021

Type / Class: Equity / COM
Symbol: MNTA

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of MOMENTA PHARMACEUTICALS INC - COM (MNTA) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2021 Q4	0	$0	-$116,000				0
2021 Q3	3,497	$116,000				$33.17	1
2020 Q4	0	$0	-$5,689,288,898	$0	$0		0
2020 Q3	108,445,471	$5,691,355,304	-$164,668,791	$56,132,000	$125,798,000	$52.48	207
2020 Q2	123,159,740	$4,100,576,953	+$256,246,091	$1,783,000	$3,923,000	$33.27	232
2020 Q1	116,138,789	$3,159,625,565	-$42,839,150	$1,020,000	$19,530,000	$27.20	192
2019 Q4	117,735,389	$2,322,812,687	+$377,640,061	$1,147,000	$4,820,000	$19.73	166
2019 Q3	98,146,932	$1,272,189,223	+$16,531,765	$1,151,000	$1,457,000	$12.96	148
2019 Q2	96,801,951	$1,205,088,986	-$13,156,819	$970,000	$843,000	$12.45	148
2019 Q1	97,895,547	$1,422,434,161	+$41,098,090	$1,020,000	$634,000	$14.53	140
2018 Q4	95,456,785	$1,053,669,471	+$134,341,832	$266,000	$765,000	$11.04	152
2018 Q3	76,285,092	$2,006,200,030	+$4,901,953	$1,409,000	$3,467,000	$26.30	155
2018 Q2	76,172,261	$1,557,590,766	+$40,663,533	$965,000	$2,235,000	$20.45	156
2018 Q1	74,525,000	$1,352,768,443	+$3,776,148	$600,000	$2,524,000	$18.15	159
2017 Q4	75,127,224	$1,048,276,122	+$17,912,714	$2,591,000	$3,735,000	$13.95	158
2017 Q3	73,246,683	$1,355,377,914	+$36,507,764	$644,000	$3,632,000	$18.50	154
2017 Q2	71,513,170	$1,208,199,731	+$109,851,246	$373,000	$3,286,000	$16.90	161
2017 Q1	65,381,841	$872,864,211	+$127,735,717	$329,000	$1,507,000	$13.35	160
2016 Q4	63,927,162	$962,164,936	+$47,477,134	$50,000	$1,733,000	$15.05	156
2016 Q3	61,165,740	$713,656,072	+$25,899,951	$510,000	$1,588,000	$11.69	148
2016 Q2	58,946,682	$636,904,675	+$18,175,673	$124,000	$656,000	$10.80	141
2016 Q1	59,380,897	$548,464,992	-$24,730,701	$1,000,000	$1,472,000	$9.24	145
2015 Q4	60,367,422	$895,822,745	-$28,501,610	$1,229,000	$1,746,000	$14.84	160
2015 Q3	62,198,818	$1,020,720,864	+$4,374,908	$3,247,000	$3,495,000	$16.41	152
2015 Q2	61,659,841	$1,406,128,363	+$268,241,662	$3,006,000	$3,954,000	$22.81	159
2015 Q1	50,614,505	$769,584,793	+$79,757,097	$898,000	$5,607,000	$15.20	139
2014 Q4	46,502,629	$559,734,536	+$22,827,371	$488,000	$3,286,000	$12.04	145
2014 Q3	44,395,330	$503,428,191	+$2,453,872	$5,151,000	$3,095,000	$11.34	143
2014 Q2	43,944,353	$530,815,480	+$2,741,830	$9,447,000	$7,594,000	$12.08	146
2014 Q1	42,690,332	$497,285,570	-$20,009,479	$9,782,000	$10,008,000	$11.65	156